Entry |
|
Name |
Lenograstim (USAN/INN); Lenograstim (genetical recombination) (JP18); Neutrogin (TN) |
Class |
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
|
Remark |
Therapeutic category: | 3399 |
|
Efficacy |
Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF) |
Comment |
Recombinant granulocyte colony stimulating factor (G-CSF) [HSA: 1440] [KO: K05423]
|
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA10 Lenograstim
D03247 Lenograstim (USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
339 Miscellaneous
3399 Others
D03247 Lenograstim (USAN/INN); Lenograstim (genetical recombination) (JP18)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D03247 Lenograstim
Drug classes [BR:br08332]
Immunological agent
DG01753 Colony stimulating factor
D03247 Lenograstim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D03247 Lenograstim (USAN/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03247 Lenograstim (genetical recombination)
|
Other DBs |
|
LinkDB |
|